Gabriel Brooks
CIK: 0001997809
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Solid Biosciences Inc.
Discretionary Trading P&L
Holdings
Transaction History (20 total)
- Oct 19, 2026SLDB
Solid Biosciences Inc.
Sale(S)Direct4.4K shares at avg. $5.62$25K - Oct 18, 2026SLDB
Solid Biosciences Inc.
Exercise(M)Direct9.8K shares- - Feb 18, 2026SLDB
Solid Biosciences Inc.
Sale(S)Direct0 shares at avg. $5.82- - Feb 13, 2026SLDB
Solid Biosciences Inc.
Exercise(M)Direct10.9K shares- - Feb 4, 2026SLDB
Solid Biosciences Inc.
Sale(S)Direct12.6K shares at avg. $6.44$81K - Feb 2, 2026SLDB
Solid Biosciences Inc.
Sale(S)Direct28.3K shares at avg. $6.44$182K - Jan 31, 2026SLDB
Solid Biosciences Inc.
Exercise(M)Direct28.2K shares- - Jan 29, 2026SLDB
Solid Biosciences Inc.
Award(A)DirectRestricted Stock Units
58.8K shares- - Jan 29, 2026SLDB
Solid Biosciences Inc.
Award(A)DirectRestricted Stock Units
103.8K shares- - Jan 29, 2026SLDB
Solid Biosciences Inc.
Exercise(M)Direct58.8K shares- - Jan 29, 2026SLDB
Solid Biosciences Inc.
Award(A)DirectEmployee Stock Option (Right to Buy)
207.5K shares- - Oct 20, 2025SLDB
Solid Biosciences Inc.
Sale(S)Direct2.9K shares at avg. $5.96$17K - Oct 18, 2025SLDB
Solid Biosciences Inc.
Exercise(M)Direct9.8K shares- - Aug 14, 2025SLDB
Solid Biosciences Inc.
Award(A)DirectRestricted Stock Units
71.3K shares- - Aug 14, 2025SLDB
Solid Biosciences Inc.
Award(A)DirectEmployee Stock Option (Right to Buy)
142.5K shares- - Feb 14, 2025SLDB
Solid Biosciences Inc.
Sale(S)Direct3.3K shares at avg. $3.96$13K - Feb 13, 2025SLDB
Solid Biosciences Inc.
Exercise(M)Direct10.9K shares- - Jan 31, 2025SLDB
Solid Biosciences Inc.
Award(A)DirectRestricted Stock Units
112.9K shares- - Oct 21, 2024SLDB
Solid Biosciences Inc.
Sale(S)Direct2.9K shares at avg. $6.50$19K - Oct 18, 2024SLDB
Solid Biosciences Inc.
Exercise(M)Direct9.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 19, 2026 | SLDB Solid Biosciences Inc. | Sale(S) | 4,374 | $5.62 | $24,582 | Direct |
| Oct 18, 2026 | SLDB Solid Biosciences Inc. | Exercise(M) | 9,750 | - | $0 | Direct |
| Feb 18, 2026 | SLDB Solid Biosciences Inc. | Sale(S) | 0 | $5.82 | $0 | Direct |
| Feb 13, 2026 | SLDB Solid Biosciences Inc. | Exercise(M) | 10,937 | - | $0 | Direct |
| Feb 4, 2026 | SLDB Solid Biosciences Inc. | Sale(S) | 12,616 | $6.44 | $81,271 | Direct |
| Feb 2, 2026 | SLDB Solid Biosciences Inc. | Sale(S) | 28,335 | $6.44 | $182,390 | Direct |
| Jan 31, 2026 | SLDB Solid Biosciences Inc. | Exercise(M) | 28,225 | - | $0 | Direct |
| Jan 29, 2026 | SLDB Solid Biosciences Inc. | Award(A) Restricted Stock Units | 58,847 | - | - | Direct |
| Jan 29, 2026 | SLDB Solid Biosciences Inc. | Award(A) Restricted Stock Units | 103,750 | - | - | Direct |
| Jan 29, 2026 | SLDB Solid Biosciences Inc. | Exercise(M) | 58,847 | - | $0 | Direct |
| Jan 29, 2026 | SLDB Solid Biosciences Inc. | Award(A) Employee Stock Option (Right to Buy) | 207,450 | - | - | Direct |
| Oct 20, 2025 | SLDB Solid Biosciences Inc. | Sale(S) | 2,895 | $5.96 | $17,254 | Direct |
| Oct 18, 2025 | SLDB Solid Biosciences Inc. | Exercise(M) | 9,750 | - | - | Direct |
| Aug 14, 2025 | SLDB Solid Biosciences Inc. | Award(A) Restricted Stock Units | 71,250 | - | - | Direct |
| Aug 14, 2025 | SLDB Solid Biosciences Inc. | Award(A) Employee Stock Option (Right to Buy) | 142,500 | - | - | Direct |
| Feb 14, 2025 | SLDB Solid Biosciences Inc. | Sale(S) | 3,256 | $3.96 | $12,894 | Direct |
| Feb 13, 2025 | SLDB Solid Biosciences Inc. | Exercise(M) | 10,937 | - | - | Direct |
| Jan 31, 2025 | SLDB Solid Biosciences Inc. | Award(A) Restricted Stock Units | 112,900 | - | - | Direct |
| Oct 21, 2024 | SLDB Solid Biosciences Inc. | Sale(S) | 2,923 | $6.50 | $19,000 | Direct |
| Oct 18, 2024 | SLDB Solid Biosciences Inc. | Exercise(M) | 9,750 | - | $0 | Direct |
1-20 of 20 transactions
About Brooks Gabriel
Brooks Gabriel (SEC CIK 0001997809) files insider reports with the SEC as Chief Medical Officer of Solid Biosciences Inc. (SLDB).
Signal8 holds 10 ownership filings by Brooks Gabriel, all Form 4s, filed between Oct 22, 2024 and Oct 20, 2026. Those filings report 20 transactions, from Oct 18, 2024 to Oct 19, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Brooks Gabriel's filings is in CHARLESTOWN, MA.
Recent filings by Brooks Gabriel
- Oct 19, 2026: Open-market sale of SLDB shares (Form 4, code S).
- Oct 18, 2026: Option exercise of SLDB shares (Form 4, code M).
- Feb 18, 2026: Open-market sale of SLDB shares (Form 4, code S).
- Feb 13, 2026: Option exercise of SLDB shares (Form 4, code M).
- Feb 4, 2026: Open-market sale of SLDB shares (Form 4, code S).
Other insiders filing for Solid Biosciences Inc. (SLDB)
- Ganot Ilan, Director
- SMITH IAN F, Director
- RA CAPITAL MANAGEMENT, L.P., 10% Owner
- Nagendran Sukumar, Director
- PERCEPTIVE ADVISORS LLC, Director
- Keresty Georgia, Director